ES8603860A1 - Procedimiento para la obtencion de derivados del benzodioxol - Google Patents
Procedimiento para la obtencion de derivados del benzodioxolInfo
- Publication number
- ES8603860A1 ES8603860A1 ES543681A ES543681A ES8603860A1 ES 8603860 A1 ES8603860 A1 ES 8603860A1 ES 543681 A ES543681 A ES 543681A ES 543681 A ES543681 A ES 543681A ES 8603860 A1 ES8603860 A1 ES 8603860A1
- Authority
- ES
- Spain
- Prior art keywords
- radical
- compound
- general formula
- alk
- given above
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
- Light Receiving Elements (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Waveguide Switches, Polarizers, And Phase Shifters (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
- Pyrane Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
PROCEDIMIENTO PARA LA OBTENCION DE DERIVADOS DEL BENZODIOXOL. CONSISTE EN HACER REACCIONAR UN COMPUESTO DE FORMULA (II) CON UN COMPUESTO DE FORMULA (III) O UN ANHIDRIDO DEL MISMO, PARA OBTENER DERIVADOS DEL BENZODIOXOL DE FORMULA (I), DONDE R1 ES UN RESTO SUSTITUIDO O INSUSTITUIDO, ALIFATICO, AROMATICO O HETEROAROMATICO; ALK ES UN RESTO ALQUILENO, ALQUENILENO O ALQUILIDENO CON UN MAXIMO DE 5 ATOMOS DE CARBONO; N1 SIGNIFICA 0, 1 O 2; N2 SIGNIFICA 0 O 1; R2, R3 Y R4 SIGNIFICAN, INDEPENDIENTEMENTE ENTRE SI, H, ALQUILO INFERIOR, ALCOXI INFERIOR O HALOGENO; Y A SIGNIFICA EL RESTO -O-R5, DONDE R5 SIGNIFICA UN RESTO HIDROCARBURO INSUSTITUIDO O SUSTITUIDO ALIFATICO O ARILALIFATICO. LA TEMPERATURA DE REACCION ESTA COMPRENDIDA ENTRE 80 Y 120JC. TIENEN APLICACIONES FARMACEUTICAS COMO DIURETICOS PROTECTORES DEL POTASIO CON EFICACIA URICOSURICA ADICIONAL.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH616382 | 1982-10-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
ES8603860A1 true ES8603860A1 (es) | 1986-01-01 |
ES543681A0 ES543681A0 (es) | 1986-01-01 |
Family
ID=4305256
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES526609A Granted ES526609A0 (es) | 1982-10-22 | 1983-10-20 | Procedimiento para la obtencion de derivados de benzodioxol |
ES543683A Expired ES8703449A1 (es) | 1982-10-22 | 1985-05-30 | Procedimiento para la obtencion de derivados del benzodioxol |
ES543684A Expired ES8703450A1 (es) | 1982-10-22 | 1985-05-30 | Procedimiento para la obtencion de derivados del benzodioxol |
ES543682A Expired ES8608506A1 (es) | 1982-10-22 | 1985-05-30 | Procedimiento para la obtencion de derivados del benzodioxol |
ES543681A Granted ES543681A0 (es) | 1982-10-22 | 1985-05-30 | Procedimiento para la obtencion de derivados del benzodioxol |
Family Applications Before (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES526609A Granted ES526609A0 (es) | 1982-10-22 | 1983-10-20 | Procedimiento para la obtencion de derivados de benzodioxol |
ES543683A Expired ES8703449A1 (es) | 1982-10-22 | 1985-05-30 | Procedimiento para la obtencion de derivados del benzodioxol |
ES543684A Expired ES8703450A1 (es) | 1982-10-22 | 1985-05-30 | Procedimiento para la obtencion de derivados del benzodioxol |
ES543682A Expired ES8608506A1 (es) | 1982-10-22 | 1985-05-30 | Procedimiento para la obtencion de derivados del benzodioxol |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP0107622B1 (es) |
JP (1) | JPS5995284A (es) |
AT (1) | ATE30722T1 (es) |
AU (1) | AU567894B2 (es) |
CA (1) | CA1223874A (es) |
DE (1) | DE3374408D1 (es) |
DK (1) | DK485583A (es) |
ES (5) | ES526609A0 (es) |
FI (1) | FI833819A (es) |
GR (1) | GR78709B (es) |
IE (1) | IE56092B1 (es) |
IL (1) | IL70005A0 (es) |
NO (1) | NO833857L (es) |
NZ (1) | NZ206035A (es) |
PT (1) | PT77539B (es) |
ZA (1) | ZA837811B (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0158596A3 (de) * | 1984-04-06 | 1986-08-13 | Ciba-Geigy Ag | Neue substituierte Benzodioxolderivate, Verfahren zu deren Herstellung und entsprechende pharmazeutische Zusammensetzungen |
US6169107B1 (en) | 1993-04-28 | 2001-01-02 | Sumitomo Pharmaceutical Co., Ltd. | Indoloylguanidine derivatives |
CA2585172C (en) | 2004-10-29 | 2014-08-12 | Kalypsys, Inc. | Sulfonyl-substituted bicyclic compounds as modulators of ppar |
HUE040020T2 (hu) | 2005-10-25 | 2019-02-28 | Kalypsys Inc | PPAR modulátorok sói és eljárások metabolikus betegségek kezelésére |
CN101007798B (zh) * | 2006-01-24 | 2011-01-26 | 中国人民解放军军事医学科学院毒物药物研究所 | 苯并间二氧杂环戊烯衍生物及其制备方法和医药用途 |
CN101007804B (zh) * | 2006-01-25 | 2011-05-11 | 中国人民解放军军事医学科学院毒物药物研究所 | 1,3-苯并间二氧杂环戊烯-2,2-二羧酸衍生物、其制备方法和医疗用途 |
WO2008091863A1 (en) | 2007-01-23 | 2008-07-31 | Kalypsys, Inc. | Sulfonyl-substituted bicyclic compounds as ppar modulators for the treatment of non-alcoholic steatohepatitis |
BR112013007495A2 (pt) * | 2010-10-04 | 2024-03-12 | Firmenich & Cie | Derivados de benzodioxol como odorantes aquosos |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3872105A (en) * | 1973-06-11 | 1975-03-18 | Merrell Inc Richard | Derivatives of 1,3-benzodioxole-2-carboxylic acid |
GR75464B (es) * | 1981-04-24 | 1984-07-20 | Ciba Geigy | |
EP0107623A1 (de) * | 1982-10-22 | 1984-05-02 | Ciba-Geigy Ag | Neue Benzodioxolderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen |
-
1983
- 1983-10-17 AT AT83810479T patent/ATE30722T1/de not_active IP Right Cessation
- 1983-10-17 EP EP83810479A patent/EP0107622B1/de not_active Expired
- 1983-10-17 DE DE8383810479T patent/DE3374408D1/de not_active Expired
- 1983-10-19 IL IL70005A patent/IL70005A0/xx unknown
- 1983-10-19 FI FI833819A patent/FI833819A/fi not_active Application Discontinuation
- 1983-10-20 PT PT77539A patent/PT77539B/pt unknown
- 1983-10-20 ZA ZA837811A patent/ZA837811B/xx unknown
- 1983-10-20 GR GR72757A patent/GR78709B/el unknown
- 1983-10-20 ES ES526609A patent/ES526609A0/es active Granted
- 1983-10-20 CA CA000439384A patent/CA1223874A/en not_active Expired
- 1983-10-21 NZ NZ206035A patent/NZ206035A/en unknown
- 1983-10-21 NO NO833857A patent/NO833857L/no unknown
- 1983-10-21 IE IE2472/83A patent/IE56092B1/xx unknown
- 1983-10-21 DK DK485583A patent/DK485583A/da not_active Application Discontinuation
- 1983-10-21 JP JP58196274A patent/JPS5995284A/ja active Pending
- 1983-10-21 AU AU20489/83A patent/AU567894B2/en not_active Ceased
-
1985
- 1985-05-30 ES ES543683A patent/ES8703449A1/es not_active Expired
- 1985-05-30 ES ES543684A patent/ES8703450A1/es not_active Expired
- 1985-05-30 ES ES543682A patent/ES8608506A1/es not_active Expired
- 1985-05-30 ES ES543681A patent/ES543681A0/es active Granted
Also Published As
Publication number | Publication date |
---|---|
ES8703449A1 (es) | 1987-02-16 |
NO833857L (no) | 1984-04-24 |
ES543683A0 (es) | 1987-02-16 |
FI833819A0 (fi) | 1983-10-19 |
EP0107622A1 (de) | 1984-05-02 |
AU567894B2 (en) | 1987-12-10 |
EP0107622B1 (de) | 1987-11-11 |
JPS5995284A (ja) | 1984-06-01 |
ES8608506A1 (es) | 1986-06-16 |
GR78709B (es) | 1984-09-27 |
PT77539A (en) | 1983-11-01 |
ZA837811B (en) | 1984-08-29 |
ES8703450A1 (es) | 1987-02-16 |
CA1223874A (en) | 1987-07-07 |
NZ206035A (en) | 1987-03-06 |
ES543684A0 (es) | 1987-02-16 |
DE3374408D1 (en) | 1987-12-17 |
DK485583A (da) | 1984-04-23 |
PT77539B (en) | 1986-05-28 |
FI833819A (fi) | 1984-04-23 |
IE832472L (en) | 1984-04-22 |
DK485583D0 (da) | 1983-10-21 |
ES8601959A1 (es) | 1985-11-16 |
ES543681A0 (es) | 1986-01-01 |
ATE30722T1 (de) | 1987-11-15 |
ES526609A0 (es) | 1985-11-16 |
ES543682A0 (es) | 1986-06-16 |
IL70005A0 (en) | 1984-01-31 |
AU2048983A (en) | 1984-05-03 |
IE56092B1 (en) | 1991-04-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE15185T1 (de) | Benzhydrylsulfinylacetamid-derivate und deren verwendung in der therapeutik. | |
ES410732A1 (es) | Procedimiento para la preparacion de derivados olefinicos de piperidino-4-sustituidos. | |
MY104376A (en) | N-imidazolyl deravatives of bicyclic compounds and process for their preparation. | |
DE3374408D1 (en) | Benzodioxole derivatives, process for their preparation and pharmaceutical compositions containing them | |
ES8604543A1 (es) | Procedimiento para la obtencion de derivados piperazinicos | |
US2701253A (en) | Substituted dithiolanes | |
GB1384479A (en) | Phosphorus-containing amidines | |
NZ213222A (en) | 2-(3,5-dialkyl-4-hydroxyphenyl)-indole derivatives and pharmaceutical compositions | |
ES540332A0 (es) | Procedimiento para preparar nuevos pirimido (2,1-b) benzo- tiazoles | |
JPS5781469A (en) | Antifungal ethenylimidazole derivative, manufacture, pharmaceutical composition containing same, intermediate useful for manufacture and manufacture of said intermediate | |
ES8406452A1 (es) | Procedimiento para la obtencion de nuevos derivados de benzazol. | |
ES8702380A1 (es) | Procedimiento para preparar un derivado de (imina ciclica)- difenil-eter | |
ZA852359B (en) | Enkephalinase inhibitors | |
GB1156781A (en) | New Heterocyclic Compounds | |
ES475004A1 (es) | Un procedimiento para la preparacion de sales de eteres del acido clavulanico | |
GB1514514A (en) | Bispiperazido phosphorus and trispiperazidophosphorus compounds | |
ES8207543A1 (es) | Un procedimiento para la preparacion de nuevos derivados heterotriciclicos jaula. | |
ES8609288A1 (es) | Un procedimiento para preparar un derivado de tiazolidina | |
RO85269B (ro) | Procedeu de preparare a unor derivati de 1, 2, 4-oxadiazina | |
ZA827040B (en) | Triazinyallactams,a process for their preparation,their use as stabilizers for synthetic organic polymers and the polymers stabilized with them |